Genomic Medicine Research Center (유전체맞춤의학연구센터)
Results 1-20 of 40 (Search time: 0.002 seconds).
No. | Year | Title | Type |
---|---|---|---|
40 | 2025 | 2025Article Anti-proteolytic regulation of KRAS by USP9X/NDRG3 in KRAS-driven cancer developmentNature Communications, vol. 16, pp. 628-628Han Koo; Kyung Chan Park; Hyun Ahm Sohn; Minho Kang; D J Kim; Z Y Park; S Park; S H Min; Seong-Hwan Park; Yeon Mi You, et al. |
Article |
39 | 2025 | 2025Research Project KRAS 안정성 조절인자 NDRG3 표적화 췌장암 제어용 이중기능성 유효/선도물질 도출연구책임자 : 이동철 / 사업기간 : 2025.01.01 ~ 2025.04.30 |
Research Project |
38 | 2025 | 2025Research Project 바이오 빅데이터 기반 난치성 암 맞춤의약 원천기술 개발 = Bio big-data driven study for targeted therapy of currently untreatable cancers연구책임자 : 김선영 / 사업기간 : 2025.01.01 ~ 2025.12.31 |
Research Project |
37 | 2024 | 2024Article Exosomal miR-196b secreted from bronchial epithelial cells chronically exposed to low-dose PM2.5 promotes invasiveness of adjacent and lung cancer cellsToxicology Letters, vol. 399, pp. 9-18S L Yu; Han Koo; Y Kang; H J Jeon; Minho Kang; D H Choi; S Y Lee; J W Son; Dong Chul Lee |
Article |
36 | 2024 | 2024Research Project 바이오 빅데이터 기반 난치성 암 맞춤의약 원천기술 개발 = Bio big-data driven study for targeted therapy of currently untreatable cancers연구책임자 : 박경찬 / 사업기간 : 2024.01.01 ~ 2024.12.31 |
Research Project |
35 | 2024 | 2024Research Project 암대사형 악성 진화 유도인자 발굴과 분자기전 규명연구책임자 : 박경찬 / 사업기간 : 2024.06.11 ~ 2025.01.31 |
Research Project |
34 | 2023 | 2023Research Project 바이오 빅데이터 기반 난치성 암 맞춤의약 원천기술 개발 = Bio big-data driven study for targeted therapy of currently untreatable cancers연구책임자 : 박경찬 / 사업기간 : 2023.01.01 ~ 2023.12.31 |
Research Project |
33 | 2023 | 2023Research Project 종양대식세포(TAM)의 암 촉진성 형질분화 조절을 통한 고형암 치료기술 개발 = Development of solid cancer treatment technology through regulation of tumor-promoting traits of tumor macrophages (TAM)연구책임자 : 박경찬 / 사업기간 : 2023.03.01 ~ 2024.02.29 |
Research Project |
32 | 2023 | 2023Article Exosomal miR-205-5p improves endometrial receptivity by upregulating E-cadherin expression through ZEB1 inhibitionInternational Journal of Molecular Sciences, vol. 24, no. 20, pp. 15149-15149S L Yu; D U Jeong; E J Noh; H J Jeon; Dong Chul Lee; Minho Kang; T H Kim; S K Lee; A R Han; J Kang, et al. |
Article |
31 | 2023 | 2023Research Project 암 대사유형별 최적약물 및 대사유전자 스크린연구책임자 : 박경찬 / 사업기간 : 2023.06.12 ~ 2024.01.31 |
Research Project |
30 | 2022 | 2022Article Combination of a STAT3 inhibitor with anti-PD-1 immunotherapy is an effective treatment regimen for a vemurafenib-resistant melanoma = 베무라페닙 내성 흑색종에 대한 효과적 치료법인 STAT3 억제제와 항 PD-1 면역 요법의 조합Molecular Therapy-Oncolytics, vol. 26, pp. 1-14T W Kim; Y Kim; H Keum; W Jung; Minho Kang; S Jon |
Article |
29 | 2022 | 2022Article Synaptotagmin 11 scaffolds MKK7-JNK signaling process to promote stem-like molecular subtype gastric cancer oncogenesisJournal of Experimental & Clinical Cancer Research, vol. 41, pp. 212-212Bo Kyung Kim; Da Mi Kim; Hyunkyung Park; Seon-Kyu Kim; Mi Aie Hwang; Jungwoon Lee; Mi-Jung Kang; Jae Eun Byun; Joo-Young Im; Minho Kang, et al. |
Article |
28 | 2022 | 2022Research Project 종양대식세포(TAM)의 암 촉진성 형질분화 조절을 통한 고형암 치료기술 개발 = Development of solid cancer treatment technology through regulation of tumor-promoting traits of tumor macrophages (TAM)연구책임자 : 박경찬 / 사업기간 : 2022.03.01 ~ 2023.02.28 |
Research Project |
27 | 2022 | 2022Article R-PTP-κ inhibits contact-dependent cell growth by suppressing E2F activityBiomedicines, vol. 10, no. 12, pp. 3199-3199Hyun Ahm Sohn; Minho Kang; H Ha; Young Il Yeom; Kyung Chan Park; Dong Chul Lee |
Article |
26 | 2022 | 2022Research Project 바이오 빅데이터 기반 난치성 암 맞춤의약 원천기술 개발 = Bio big-data driven study for targeted therapy of currently untreatable cancers연구책임자 : 박경찬 / 사업기간 : 2022.01.01 ~ 2022.12.31 |
Research Project |
25 | 2022 | 2022Research Project 대사표현형 바이오마커기반 암 유형의 암생물학적 특성 규명과 정밀치료전략 개발 및 임상응용성 연구 = Characterization of cancers classified based on metabo-phenotypic biomarkers and development of translational strategies for연구책임자 : 염영일 / 사업기간 : 2022.03.01 ~ 2022.11.04 |
Research Project |
24 | 2022 | 2022Article Glycogen storage disease phenotypes accompanying the perturbation of the methionine cycle in NDRG3-deficient mouse liversCells, vol. 11, no. 9, pp. 1536-1536Hyun Ahm Sohn; Dong Chul Lee; Anna Park; Minho Kang; Byoung-Ha Yoon; Chul-Ho Lee; Yong-Hoon Kim; Kyoung-Jin Oh; Cha Yeon Kim; Seong-Hwan Park, et al. |
Article |
23 | 2021 | 2021Research Project 종양대식세포(TAM)의 암 촉진성 형질분화 조절을 통한 고형암 치료기술 개발 = Development of solid cancer treatment technology through regulation of tumor-promoting traits of tumor macrophages (TAM)연구책임자 : 박경찬 / 사업기간 : 2021.03.01 ~ 2022.02.28 |
Research Project |
22 | 2021 | 2021Research Project 다중유전체 분석을 통한 비흡연폐암의 신규치료타겟 발굴 및 기전규명연구책임자 : 박경찬 / 사업기간 : 2021.01.01 ~ 2022.03.31 |
Research Project |
21 | 2021 | 2021Research Project 암 특이대사와 젖산유래 세포신호체계의 동반조절 기전분석 및 대사성 종 양 맞춤치료기술 개발 = Understanding of a molecular mechanism for the simultaneous regulation of cancer metabolism and lactate signaling to develop연구책임자 : 염영일 / 사업기간 : 2021.01.01 ~ 2021.08.28 |
Research Project |